{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:39:19Z","timestamp":1784036359228,"version":"3.55.0"},"reference-count":45,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"unspecified","delay-in-days":339,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2024]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:p>Serogroup epidemiology of invasive meningococcal disease (IMD) is constantly evolving, varying by time and location. Surveillance reports have indicated a rise in meningococcal serogroup Y (MenY) in some regions in recent years. This systematic literature review explores the evolving epidemiology of MenY IMD globally based on review of recent articles and national surveillance reports published between 1 January 2010 and 25 March 2021. Generally, MenY incidence was low (&lt;0.2\/100,000) across all ages in most countries. The reported incidence was more frequent among infants, adolescents, and those aged \u226565\u00a0years. More than 10% of all IMD cases were MenY in some locations and time periods. Implementation of vaccination evolved over time as the rise in MenY IMD percentage occurred. Cases decreased in countries with quadrivalent vaccine programs (e.g., United Kingdom, the Netherlands, United States, and Australia), whereas the MenY burden increased and made up a large proportion of cases in areas without vaccine programs. Continuous monitoring of epidemiologic changes of IMD is essential to establish MenY burden and for implementation of prevention strategies.<\/jats:p>","DOI":"10.1017\/s0950268824001535","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T11:16:18Z","timestamp":1733397378000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":3,"title":["Global epidemiology of serogroup Y invasive meningococcal disease: a literature review"],"prefix":"10.1017","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6148-3101","authenticated-orcid":false,"given":"Myint","family":"Tin Tin Htar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5153-4043","authenticated-orcid":false,"given":"Jamie","family":"Findlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8188-1791","authenticated-orcid":false,"given":"Paul","family":"Balmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1653-6646","authenticated-orcid":false,"given":"David","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"S0950268824001535_r38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.06.008"},{"key":"S0950268824001535_r39","unstructured":"[39] Le Laboratoire de Sant\u00e9 Publique du Qu\u00e9bec. Bulletin STATLABO. Available at https:\/\/www.inspq.qc.ca\/lspq\/nos-productions\/bulletin-statlabo (accessed 17 November 2022)."},{"key":"S0950268824001535_r5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2016.04.012"},{"key":"S0950268824001535_r43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2019.11.001"},{"key":"S0950268824001535_r30","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29678"},{"key":"S0950268824001535_r40","unstructured":"[40] BC Centre for Disease Control. CD Annual Report Archives. Available at http:\/\/www.bccdc.ca\/health-professionals\/data-reports\/communicable-diseases\/cd-annual-report-archives (accessed 17 November 2022)."},{"key":"S0950268824001535_r33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186839"},{"key":"S0950268824001535_r35","unstructured":"[35] New Zealand Ministry of Health. Meningococcal Disease Reports (2022). Available at https:\/\/surv.esr.cri.nz\/surveillance\/Meningococcal_disease.php (accessed 13 October 2022)."},{"key":"S0950268824001535_r10","unstructured":"[10] European Centre for Disease Prevention and Control (2024). Surveillance Atlas of Infectious Diseases: Invasive Meningococcal Disease. Available at https:\/\/atlas.ecdc.europa.eu\/public\/index.aspx?Dataset=27&HealthTopic=36 (accessed 19 August 2024)."},{"key":"S0950268824001535_r12","unstructured":"[12] Australian Government Department of Health and Aged Care (2023). Australian Meningococcal Surveillance Programme (AMSP) Annual Reports. Available at https:\/\/www1.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cda-pubs-annlrpt-menganrep.htm (accessed 13 October 2022)."},{"key":"S0950268824001535_r21","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v40i09a01"},{"key":"S0950268824001535_r19","unstructured":"[19] Centers for Disease Control and Prevention. Enhanced Meningococcal Disease Surveillance Reports. Available at https:\/\/www.cdc.gov\/meningococcal\/surveillance\/index.html#enhanced-reports (accessed 13 October 2022)."},{"key":"S0950268824001535_r18","unstructured":"[18] Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs), Neisseria meningitidis. Available at https:\/\/www.cdc.gov\/abcs\/reports-findings\/surv-reports.html (accessed 13 October 2022)."},{"key":"S0950268824001535_r8","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.063"},{"key":"S0950268824001535_r3","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-346-2_1"},{"key":"S0950268824001535_r22","unstructured":"[22] Centers for Disease Control and Prevention. Meningococcal Vaccination. Available at https:\/\/www.cdc.gov\/meningococcal\/vaccine-info.html (accessed 12 October 2022)."},{"key":"S0950268824001535_r32","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1507261"},{"key":"S0950268824001535_r34","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14771"},{"key":"S0950268824001535_r28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-310"},{"key":"S0950268824001535_r44","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz578"},{"key":"S0950268824001535_r24","unstructured":"[24] Group for Enteric Respiratory and Meningeal Disease Surveillance in South Africa. GERMS-SA Annual Surveillance Review 2019. Available at https:\/\/www.nicd.ac.za\/wp-content\/uploads\/2021\/02\/GERMS-Annual-Review-2019_.pdf (accessed 2 March 2022)."},{"key":"S0950268824001535_r29","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.06.018"},{"key":"S0950268824001535_r26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046019"},{"key":"S0950268824001535_r17","doi-asserted-by":"publisher","DOI":"10.1086\/649209"},{"key":"S0950268824001535_r37","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.08.023"},{"key":"S0950268824001535_r42","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2021.1971289"},{"key":"S0950268824001535_r36","unstructured":"[36] Organizaci\u00f3n Panamericana de la Salud. Informe Regional de SIREVA II (2018). Available at https:\/\/www.paho.org\/es\/sireva (accessed 13 October 2022)."},{"key":"S0950268824001535_r20","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01077-09"},{"key":"S0950268824001535_r2","unstructured":"[2] World Health Organization. Meningitis (2023). Available at http:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/meningococcal-meningitis (accessed 22 November 2024)."},{"key":"S0950268824001535_r9","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-019-0254-1"},{"key":"S0950268824001535_r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2013.11.012"},{"key":"S0950268824001535_r27","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy914"},{"key":"S0950268824001535_r31","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1209278"},{"key":"S0950268824001535_r13","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00401-12"},{"key":"S0950268824001535_r23","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1855952"},{"key":"S0950268824001535_r1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2018.00321"},{"key":"S0950268824001535_r11","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.3.2002075"},{"key":"S0950268824001535_r7","unstructured":"[7] World Health Organization (2020) The Immunological Basis for Immunization Series: Module 15: Meningococcal Disease. Available at https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/339965\/9789240017481-eng.pdf?sequence=1&isAllowed=y (accessed 23 September 2022)."},{"key":"S0950268824001535_r15","doi-asserted-by":"publisher","DOI":"10.5694\/mja16.01340"},{"key":"S0950268824001535_r4","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.09.010409"},{"key":"S0950268824001535_r41","unstructured":"[41] Centre D\u2019expertise et de R\u00e9f\u00e9rence en Sant\u00e9 Publique. Maladies \u00e9vitables par la vaccination \u00e0 d\u00e9claration obligatoire au Qu\u00e9bec : rapport de surveillance 2014\u20132017. Available at https:\/\/www.inspq.qc.ca\/publications\/2508 (accessed 17 November 2022)."},{"key":"S0950268824001535_r6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix993"},{"key":"S0950268824001535_r25","unstructured":"[25] Group for Enteric Respiratory and Meningeal Disease Surveillance in South Africa. GERMS-SA Annual Report 2010. Available at https:\/\/www.nicd.ac.za\/wp-content\/uploads\/2022\/06\/2010-GERMS-SA-Annual-report-Final.pdf (accessed 14 July 2022)."},{"key":"S0950268824001535_r45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.079"},{"key":"S0950268824001535_r14","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz358"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268824001535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T11:16:25Z","timestamp":1733397385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268824001535\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":45,"alternative-id":["S0950268824001535"],"URL":"https:\/\/doi.org\/10.1017\/s0950268824001535","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"\u00a9 The Author(s), 2024. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e157"}}